Nikolai E. Shcheglov

Nikolai E. Shcheglov

Auto-generated profile, based on publicly available information

Nikolai E. Shcheglov

City Clinical Hospital №52, Moscow

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
RTRuslan N. Trushkin
Ruslan N. Trushkin
TITeymur K. Isaev
Teymur K. Isaev
PMPavel E. Medvedev
Pavel E. Medvedev
NSNikolai E. Shcheglov
Nikolai E. Shcheglov
VVValerii V. Variasin
Valerii V. Variasin
LKLaura A. Kesaeva
Laura A. Kesaeva
Introduction: Kidney transplantation is the optimal treatment modality for patients with end-stage chronic kidney disease. The long-term mortality of kidney recipients is 48–82% lower than that of patients on the waiting list. However, the risk of developing malignancies in these patients is twice as high as in the healthy population. Specifically, the incidence of renal cell carcinoma (RCC) in transplant recipients is 10–30 times higher than in non-transplanted patients. The reason for the increased risk is poorly understood, but is most likely related to continuous immunosuppressive therapy. The problem of kidney graft neoplasia has not been adequately addressed in the medical literature. Objective: To determine the incidence of renal cell carcinoma in transplanted kidneys, enhance the efficacy of its treatment, and study the etiology of RCC development. Materials and methods: A retrospective analysis of RCC incidence in kidney grafts was conducted in 3,270 patients who underwent kidney transplantation between 2013 and 2023. We evaluated the effectiveness of surgical interventions for these complications. Patients with histologically confirmed RCC of the transplanted kidney underwent genetic study to determine the etiology of the neoplasm. Results: The incidence of RCC in transplanted kidneys was found to be 0.95% (n = 31), 28 patients underwent laparoscopic resection of the renal transplant tumor, 2 patients were treated with radiofrequency ablation of the tumor. Transplantectomy was performed in 1 patient. Conclusion: Laparoscopic resection is an effective and safe method for the treatment of RCC in kidney transplants. Transplanted kidney cancer originates from the donor tissue. The clear cell variant of transplanted kidney cancer is a genetically determined disease.

4 May 2025 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
RTRuslan N. Trushkin
Ruslan N. Trushkin
NONikolai A. Ognerubov
Nikolai A. Ognerubov
SSSergey A. Sokolov
Sergey A. Sokolov
SDSergey A. Dolgov
Sergey A. Dolgov
NSNikolai E. Shcheglov
Nikolai E. Shcheglov
ЩЕЩеглов Николай Евгеньевич
Щеглов Николай Евгеньевич
Background. Adrenal ectopy is a congenital anomaly of the endocrine system. It occurs in less than 1% of the adult population. Ectopy lesions consist mainly of cortex and a minimal amount of medulla. Ectopic adenomas of the adrenal cortex are small, non-functional, asymptomatic, and usually found incidentally. They are found in the kidney only in 0.1–0.6% of observations. Aim. To present a rare case of non-functioning ectopic adrenocortical adenoma in the renal sinus. Results. A 56-year-old man underwent a routine medical examination, and an ultrasound showed a tumor in the renal sinus. According to X-ray computerized and contrast-enhanced magnetic resonance imaging (MRI), a soft tissue vascularized mass in the renal sinus on the right was found, 29×15×20 mm in size. The density on the Hounsfield scale was +15HU with heterogeneous contrast uptake (up to +75HU), and the mass was closely adjacent to the renal artery and vein. No abnormalities were detected in the adrenal glands. According to MRI, the tumor had a heterogeneous structure with a signal reduction in T2 mode with diffusion restriction. Morphological verification was impossible due to anatomical features. A nephrectomy was performed for suspected renal cell carcinoma of the renal hilum. In pathohistological examination, the tumor was represented by light and eosinophilic cells; immunohistochemistry revealed a pronounced expression of SF1, Melan A, and CYP11B2 biomarkers. Ectopic cortical adrenal adenoma in the renal sinus was diagnosed. The patient was examined in 3 months, and no recurrence or functional activity was detected. Conclusion. Ectopic adrenocortical adenoma in the renal sinus is extremely rare and usually non-functional. X-ray computed tomography and MRI are sensitive methods for localizing ectopic adrenal tumors. The density value of the mass in the native mode of 10–20 HU indicates a high intracellular lipid content. A surgical method is recommended for the treatment of functional and non-functional adenomas. The final diagnosis is established by histological and immunohistochemical examinations.

5 December 2025 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
RTRuslan N. Trushkin
Ruslan N. Trushkin
NONikolai A. Ognerubov
Nikolai A. Ognerubov
SSSergey A. Sokolov
Sergey A. Sokolov
SGStanislav I. Gorshkov
Stanislav I. Gorshkov
NSNikolai E. Shcheglov
Nikolai E. Shcheglov
ЩЕЩеглов Николай Евгеньевич
Щеглов Николай Евгеньевич
The horseshoe kidney (HK) is the most common congenital anomaly of the urinary system, detected in 0.25% of the population. It combines several anatomical defects, including ectopia, malrotation, anomalies of the collecting system, and variations in the blood supply, which are associated with complications that can lead to end-stage renal disease (ESRD). The use of peritoneal dialysis and hemodialysis for this indication is a risk factor for renal cell carcinoma (RCC). HK is associated with various benign and malignant neoplasms. RCC and transitional cell carcinoma are the most common, accounting for 85% and 10% of all cases, respectively. According to the literature, renal transplant recipients are at an increased risk of RCC, predominantly involving their own kidneys. Additionally, kidney recipients who are on persistent immunosuppression are 4–15 times more likely to develop RCC. The article presents a unique case of surgical treatment of HK RCC in a 47-year-old patient who was treated for hypertension from the age of 20, and at the age of 36, he was diagnosed with HK according to ultrasound. At the age of 37, the patient developed ESRD. Peritoneal dialysis and hemodialysis were performed, followed by cadaveric kidney allotransplantation at the age of 42. The patient received continuous immunosuppression. After 5 years, gross hematuria appeared. When examined with native X-ray computed tomography and contrast-enhanced magnetic resonance imaging, a rounded mass with a clear, even outer contour, measuring up to 73×80 mm in size, and a heterogeneous structure without invasion into the fat tissue was visualized in the left half of the HK in the middle segment. Laparoscopic heminephrectomy was performed on the left. Histological examination showed papillary RCC, the resection margins were negative. Creatinine levels were stable. Diagnosis: Stage III renal cell carcinoma pT3aN0M0R0. The patient was assessed after 16 months; no evidence of recurrence was found. The case presented describes a rare case of HK RCC that developed after dialysis and kidney transplantation for ESRD. The patient successfully underwent laparoscopic heminephrectomy with a favorable outcome, with no signs of recurrence of the disease for 16 months. No such cases were reported in the literature.